منابع مشابه
Intravenous amiodarone.
Intravenous amiodarone was approved in 1995 for the treatment of malignant and resistant ventricular arrhythmia. Although it is an "old drug," much has been learned recently about this complex drug and its application in a variety of cardiac arrhythmias. The objectives of this review were to summarize what is known about intravenous amiodarone, including its pharmacologic and electrophysiologic...
متن کاملIntravenous Amiodarone for Supraventricular Arrhythmias in Children
In this issue of the Journal, Chang et al1 present a thought-provoking, single-center retrospective analysis of 37 patients receiving either procainamide or IV amiodarone for refractory supraventricular arrhythmias (SVA), excluding junctional ectopic tachycardia (JET). They compare the relative efficacy of the drugs, finding procainamide to be fully successful in 50% of cases, whereas amiodaron...
متن کاملPredictors of intravenous amiodarone induced liver injury
Background Intravenous (IV) amiodarone may be associated with liver injury that may necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) and its severity may help careful patient monitoring or the choice of other measures alternative to amiodarone in high risk patients. Little is known regarding predictors of AILI. Objectives To address the predictors of ...
متن کاملTorsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
We report a case of torsade de pointes after intravenous amiodarone and concurrent hypokalemia. Despite treatment cessation and correction of electrolyte abnormalities, excessive QTc prolongation was noted, which persisted for 14 days. This prolonged course for QTc normalization may be attributed to the high rate of amiodarone loading and concurrent electrolyte disturbances coupled with possibl...
متن کاملIntravenous and oral amiodarone for arrhythmias in children.
Oral amiodarone was administered to 30 children (aged one week to 14 years) for treatment of resistant or life threatening tachycardias. Five children received initial intravenous medication. The mean duration of oral treatment ranged from two weeks to 64 months (mean 23 months). Infants required a higher oral dose than older children when this was calculated on the basis of body weight but not...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1997
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(97)00069-7